SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories receives USFDA’s EIR for Tarapur API facility

09 Feb 2026 Evaluate

Ipca Laboratories has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (API) manufacturing facility situated at Tarapur. The EIR classifies the manufacturing facility as ‘Voluntary Action Indicated’ (VAI) and that this facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP). 

The USFDA had conducted an inspection at said facility from December 1, 2025 to December 5, 2025. 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1551.00 20.40 (1.33%)
05-May-2026 14:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1812.30
Dr. Reddys Lab 1272.70
Cipla 1331.40
Zydus Lifesciences 910.05
Lupin 2345.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×